Perioperative hydrocortisone reduces major complications, after pancreaticoduodenectomy, a randomized controlled trial.

Laaninen M , et al. Ann Surg 2016 . IF 8,569 (Rang A)

Hepatopancreaticoduodenectomy for Biliary Cancer.

Aoki T, et al. Ann Surg 2016 . IF 8,569 (Rang A)

Resection of the primary tumor followed by peptide receptor radionuclide therapy as upfront strategy for the treatment of G1-G2 pancreatic neuroendocrine tumors with unresectable liver metastases.
Bertani E, et al. Ann Surg Oncol 2016 . IF 3.655 (Rang B)

Does size matter in pancreatic cancer ?: Reappraisal of Tumour Dimension as a Predictor of
Outcome Beyond the TNM.
Marchegiani G, Andrianello S, Malleo G. et al. Annals of Surgery 2016. IF 8,569 (Rang A)

Portal Vein Embolization Followed by Right-Side Hemihepatectomy for Hepatocellular Carcinoma Patients: A Japanese Multi-Institutional Study.
Beppu T, Okabe H, Okuda K, et al. J Am Coll Surg 2016. IF 5.1 (Rang A)

Unexpected early tumor recurrence in patients with hepatitis C virus -related hepatocellular carcinoma undergoing interferon-free therapy: a note of caution
Reig M, Mariño Z, Perelló C et al. Journal of hepatology, 2016. IF: 11.3 (Rang A)

Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
Wahl DR, Stenmark MH, Tao Y et al.  Journal of clinical oncology, 2016;34(5):452-9. IF: 18,443 (Rang A)

Is complete liver resection without resection of synchronous lung metastases justified?
Mise Y, Kopetz S, Mehran RJ et al. Annals of Surgical Oncology, 2015 ;22:1585–1592. IF: 3.93 (Rang B)

Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival
Mise Y, Aloia TA, Brudvik KW et al.  Ann Surg. Jan 2016 IF: 8.327 (Rang A)

Drain management after pancreatoduodenectomy : reappraisal of a prospective randomized trial using risk stratification
McMillan MT, Malleo G, Bassi C et al.  J Am Coll Surg. Oct 2015  IF: 5,122 (Rang A)